Shir Kiong Lu

Y disruption, autosomal hypomethylation and poor male lung cancer survival

Saffron A.G. Willis‐Owen, Clara Domingo‐Sabugo, E. Starren et al. · Scientific Reports · 2021 · 37 citations · Full text

Integrated genomics point to immune vulnerabilities in pleural mesothelioma

Anca Năstase, Amit Kumar Mandal, Shir Kiong Lu et al. · Scientific Reports · 2021 · 22 citations · Full text

KRAS Mutation: Characterization and Its Impact on Survival Outcome of Patients with Metastatic Colorectal Cancer

Datul Damit, Ravi Sekhar Patnaik, Liling Chaw et al. · Frontiers in Bioscience-Landmark · 2022 · 12 citations · Full text

A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients

Rajiv Kumar, Shir Kiong Lu, Anna Minchom et al. · Cancer Chemotherapy and Pharmacology · 2015 · 10 citations

Phase 1B, Medicine, Metronomic Therapy +9